ORAGENICS INC Business Operations Contracts & Agreements
11 Contracts & Agreements
- Agency Agreements (2 contracts)
- Collaboration Agreements (8)
- Sales Agreements (1)
- Placement Agency Agreement dated June 25, 2024 between Oragenics, Inc. and Dawson James Securities, Inc (Filed With SEC on June 26, 2024)
- Amended and Restated Exclusive Channel Collaboration Agreement by and between Oragenics, Inc. and Eleszto Genetika, Inc. dated as of March 1, 2021(Lantibiotic ECC) (Filed With SEC on March 1, 2021)
- Sales Agent Agreement dated February 1, 2021 (Filed With SEC on February 1, 2021)
- Exclusive Channel Collaboration Agreement with Intrexon Corporation dated June 9, 2015, as amended and subsequently assigned to ActoBio Therapeutics, Inc., a wholly owned... (Filed With SEC on August 13, 2018)
- Placement Agency Agreement dated as of April 6, 2018 (Filed With SEC on April 10, 2018)
- Notice of Assignment of Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation, effective January 1, 2018 (Filed With SEC on February 16, 2018)
- Amendment No. 2 to the Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)
- Amendment No. 2 to the Exclusive Channel Collaboration Agreement between Oragenics, Inc. and Intrexon Corporation dated November 8, 2017 (Filed With SEC on November 9, 2017)
- FIRST AMENDMENT TO EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on August 15, 2016)
- EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on June 11, 2015)
- EXCLUSIVE CHANNEL COLLABORATION AGREEMENT (Filed With SEC on October 1, 2013)
